1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer
    Journal Article

    Moore, K. N.; Miller, A.; Bell-McGuinn, K. M.; Schilder, R. J.; Walker, J. L.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; Hagemann, A. R.; Gray, H. J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer
    Journal Article

    Fan, D.; Ma, J.; Bell, A. C.; Groen, A. H.; Olsen, K. S.; Lok, B. H.; Leeman, J. E.; Anderson, E.; Riaz, N.; McBride, S.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma
    Journal Article

    Sehn, L. H.; Herrera, A. F.; Flowers, C. R.; Kamdar, M. K.; McMillan, A.; Hertzberg, M.; Assouline, S.; Kim, T. M.; Kim, W. S.; Ozcan, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Journal Article

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S. S.; Chou, J.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Saltz, L. B.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Post-exertional malaise is associated with greater symptom burden and psychological distress in patients diagnosed with Chronic Fatigue Syndrome
    Journal Article

    May, M.; Milrad, S. F.; Perdomo, D. M.; Czaja, S. J.; Fletcher, M. A.; Jutagir, D. R.; Hall, D. L.; Klimas, N.; Antoni, M. H.
    Journal of Psychosomatic Research (2020)

    Fulltext@MSK | Save
  • Combined PIK3CA and FGFR inhibition with alpelisib and infigratinib in patients with PIK3CA-mutant solid tumors, with or without FGFR alterations
    Journal Article

    Hyman, D. M.; Tran, B.; Paz-Ares, L.; Machiels, J. P.; Schellens, J. H.; Bedard, P. L.; Campone, M.; Cassier, P. A.; Sarantopoulos, J.; Vaishampayan, U.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials
    Editorial

    Basch, E.; Leahy, A. B.
    Clinical Trials (2019)

    Fulltext@MSK | Save
  • Acupuncture versus cognitive behavioral therapy for insomnia in cancer survivors: A randomized clinical trial
    Journal Article

    Garland, S. N.; Xie, S. X.; DuHamel, K.; Bao, T.; Li, Q.; Barg, F. K.; Song, S.; Kantoff, P.; Gehrman, P.; Mao, J. J.
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Efficacy of vemurafenib in patients with non–small-cell lung cancer with BRAF V600 mutation: An open-label, single-arm cohort of the histology-independent VE-Basket study
    Journal Article

    Subbiah, V.; Gervais, R.; Riely, G.; Hollebecque, A.; Blay, J. Y.; Felip, E.; Schuler, M.; Gonçalves, A.; Italiano, A.; Keedy, V.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save